122 related articles for article (PubMed ID: 11894110)
1. Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies.
Hsieh TC; Lu X; Guo J; Xiong W; Kunicki J; Darzynkiewicz Z; Wu JM
Int J Oncol; 2002 Apr; 20(4):681-9. PubMed ID: 11894110
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of proliferation and expression of AR/PSA by herbal supplement Equiguard in LNCaP cells cultured in androgen-proficient FBS and androgen-deficient charcoal-stripped FBS is correlated with increased serine-15 phosphorylation of the tumor suppressor gene p53.
Lu X; Guo J; Hsieh TC; Wu JM
Anticancer Res; 2003; 23(3B):2489-98. PubMed ID: 12894532
[TBL] [Abstract][Full Text] [Related]
3. Ethanolic extracts of herbal supplement Equiguard suppress growth and control gene expression in CWR22Rv1 cells representing the transition of prostate cancer from androgen dependence to hormone refractory status.
Hsieh TC; Wu JM
Int J Oncol; 2008 Jan; 32(1):209-19. PubMed ID: 18097561
[TBL] [Abstract][Full Text] [Related]
4. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
Lu X; Hsieh TC; Wu JM
Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
[TBL] [Abstract][Full Text] [Related]
5. Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES.
Hsieh T; Chen SS; Wang X; Wu JM
Biochem Mol Biol Int; 1997 Jul; 42(3):535-44. PubMed ID: 9247711
[TBL] [Abstract][Full Text] [Related]
6. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells.
Pinto JT; Sinha R; Papp K; Facompre ND; Desai D; El-Bayoumy K
Int J Cancer; 2007 Apr; 120(7):1410-7. PubMed ID: 17205524
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
[TBL] [Abstract][Full Text] [Related]
9. Prevention and management of prostate cancer using PC-SPES: a scientific perspective.
Hsieh TC; Lu X; Chea J; Wu JM
J Nutr; 2002 Nov; 132(11 Suppl):3513S-3517S. PubMed ID: 12421879
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells.
Hsieh TC; Wu JM
Int J Oncol; 2002 Mar; 20(3):583-8. PubMed ID: 11836572
[TBL] [Abstract][Full Text] [Related]
11. Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitive human prostate cancer cells.
Hsieh TC; Wu JM
Int J Oncol; 2001 Jan; 18(1):81-8. PubMed ID: 11115542
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
13. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.
Hsieh TC; Wu JM
Exp Cell Res; 1999 May; 249(1):109-15. PubMed ID: 10328958
[TBL] [Abstract][Full Text] [Related]
14. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA].
Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562
[TBL] [Abstract][Full Text] [Related]
15. Effects of fenretinide (4-HPR) on prostate LNCaP cell growth, apoptosis, and prostate-specific gene expression.
Hsieh TC; Wu JM
Prostate; 1997 Oct; 33(2):97-104. PubMed ID: 9316650
[TBL] [Abstract][Full Text] [Related]
16. Antiandrogen-like actions of an antioxidant on survivin, Bcl-2 and PSA in human prostate cancer cells.
Gunawardena K; Campbell LD; Meikle AW
Cancer Detect Prev; 2005; 29(4):389-95. PubMed ID: 16139439
[TBL] [Abstract][Full Text] [Related]
17. Effects of PC-SPES on proliferation and expression of AR/PSA in androgen-responsive LNCaP cells are independent of estradiol.
Hsieh TC; Xiong W; Traganos F; Darzynkiewicz Z; Wu JM
Anticancer Res; 2002; 22(4):2051-60. PubMed ID: 12174883
[TBL] [Abstract][Full Text] [Related]
18. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J
Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040
[TBL] [Abstract][Full Text] [Related]
19. Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice.
Tsai CH; Lin FM; Yang YC; Lee MT; Cha TL; Wu GJ; Hsieh SC; Hsiao PW
Clin Cancer Res; 2009 Sep; 15(17):5435-44. PubMed ID: 19690196
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells.
Zaidman BZ; Wasser SP; Nevo E; Mahajna J
Int J Oncol; 2007 Oct; 31(4):959-67. PubMed ID: 17786330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
